Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kilitch Drugs (India) has informed that it enclosed a Press Release relating to the proposed divestment of entire stake in the overseas subsidiary which the company shall be releasing immediately after intimation to the exchanges.
The above information is a part of company’s filings submitted to BSE.